MS Remission Sustained Three Years Post-Stem Cell Transplant

For patients with relapsing-remitting multiple sclerosis , high-dose immunosuppressive therapy with autologous hematopoietic cell transplant is associated with sustained remission and improvements in neurologic function, according to research published online Dec. 29 in JAMA Neurology . Richard A. Nash, M.D., from the Colorado Blood Cancer Institute in Denver, and colleagues examined the safety, efficacy, and durability of MS disease stabilization for patients with RRMS who were evaluated through five years after HCT.

http://www.mentalhelp.net/poc/view_doc.php?type=news&id=169582&cn=75